Search results
Nikki Glaser Reacts to Tom Brady’s Roast Regrets, Says Kim Kardashian Called Experience “Abuse”
The Hollywood Reporter via Yahoo News· 2 hours agoAfter knocking her set out of the park at last week’s roast of Tom Brady, comedian Nikki Glaser has...
Ring announcer retires after botched boxing call: ‘No longer the world’s punching bag’
New York Post· 2 hours agoThe backlash for mistakenly calling out the wrong winner in a boxing match was enough for ring...
Dodgers call up Elieser Hernández & Eduardo Salazar for bullpen game vs. Giants
True Blue LA· 2 hours agoThe Dodgers on Wednesday called up both Elieser Hernández and Eduardo Salazar from Triple-A Oklahoma...
Earnings call: DarioHealth projects growth and profitability by 2025 By Investing.com
Investing.com· 2 hours agoIn a recent earnings call, DarioHealth Corp (NASDAQ:DRIO) CEO Erez Raphael outlined the company's...
Earnings call: Ondas Holdings reports a decline in revenues compared to last year By Investing.com
Investing.com· 1 hour ago(ONDS) reported a challenging start to the first quarter of 2024 but remains optimistic about its...
Earnings call: Forza X1 reports strategic shift amid marine EV market slowdown By Investing.com
Investing.com· 1 hour agoForza X1, Inc. (ticker: FX1) has announced a strategic pivot in response to the current economic...
Fans Call Jason Kelce a 'Troublemaker' in 'Unhinged' Podcast Clip
Parade· 1 hour agoLeave it to Jason Kelce to stir up chaos while filming his and brother Travis Kelce's New Heights...
UNH Senate faculty call for investigation into response to Pro-Palestinian protestors
WMUR New Hampshire· 1 hour agoThe University of New Hampshire senate faculty are calling for a closer look at the police response...
Chad Daybell trial live: Jurors hear jail phone call with Lori Vallow revealing he was texting her...
The Independent US via AOL· 3 hours agoThe children were found buried in Daybell’s Idaho backyard nine months after they went missing in...
Earnings call: Lumos Pharma gears up for Phase 3 trial of LUM-201 By Investing.com
Investing.com· 2 hours agoLumos Pharma (NASDAQ:LUMO), a biopharmaceutical company, detailed their progression towards a Phase...